IIIV
i3 Verticals, Inc.
IIIV has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over IIIV overall, supported by stronger fundamentals and stronger modeled upside.
IIIV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Under pressure |
IIIV's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
IIIV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $2.35 | -87% |
| Forward | 15x | $18.64 | — |
| Fair | 28x | $11.67 | -37% |
| Expensive | 40x | $16.63 | -11% |
| Current | 44x | $18.64 | — |
Historical ranges are pointers, not guarantees.
IIIV's PE is in its expensive range at 44x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over IIIV in the historical PE scenario, which offers more potential upside but is not a forecast.
IIIV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect IIIV's earnings to grow and its profitability to improve, with its revenue holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over IIIV on the outlook, with more favorable revenue expectations.
IIIV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.22 | +191% |
| Q2 2026 | $0.42 | -92% |
| Q1 2026 | $0.74 | -83% |
| Q4 2025 | $0.66 | -85% |
| Q3 2025 | $0.72 | -84% |
| Q2 2025 | $5.22 | +$5.26 |
| Q1 2025 | $4.40 | +7233% |
| Q4 2024 | $4.49 | +$4.51 |
| Q3 2024 | $4.45 | +$4.52 |
IIIV's earnings per share have fallen from their peak: $0.42 over the past year, against $5.22 in mid-2025.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over IIIV in the latest year-over-year earnings comparison.
IIIV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $53.1M | +2.2% |
| Q1 2026 | $57.5M | -8.8% |
| Q4 2025 | $52.7M | -15% |
| Q3 2025 | $54.9M | -9.8% |
| Q2 2025 | $51.9M | -7.4% |
| Q1 2025 | $63.1M | -33% |
| Q4 2024 | $61.7M | -33% |
| Q3 2024 | $60.9M | -37% |
IIIV's revenue has slid since its 2019 peak: $53M last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.7% | +7.6 points |
| Q1 2026 | 6.5% | +0.2 points |
| Q4 2025 | 3% | -1.3 points |
| Q3 2025 | 2.7% | -3.1 points |
| Q2 2025 | -9.3% | -8.1 points |
| Q1 2025 | 6.3% | -3.7 points |
| Q4 2024 | 4.4% | -4.9 points |
| Q3 2024 | 5.8% | -3.3 points |
IIIV's operating margin was −1.7% last quarter, up 7.6 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over IIIV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over IIIV on profitability, with a higher operating margin.
IIIV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $13M | +90% |
| Q1 2026 | $9.6M | +$37.2M |
| Q4 2025 | $13.8M | +25% |
| Q3 2025 | $13.5M | +14% |
| Q2 2025 | $6.8M | -5.7% |
| Q1 2025 | -$27.6M | -345% |
| Q4 2024 | $11M | -11% |
| Q3 2024 | $11.8M | +213% |
IIIV has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
IIIV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -36% | -11M shares |
| 1 year | -42% | -14.4M shares |
| 3 years | -43% | -14.7M shares |
| 5 years | +2.2% | +415K shares |
| Available history | +86% | +9.1M shares |
IIIV has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $48.1M |
| Q1 2026 | $50.9M |
| Q4 2025 | $37.9M |
| Q3 2025 | — |
| Q2 2025 | $26.1M |
| Q1 2025 | $308,000 |
| Q4 2024 | $11.2M |
| Q3 2024 | $29,000 |
IIIV spent $137M buying back its own shares over the past year, about four times what it spent the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
IIIV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
IIIV's net debt is about 3.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over IIIV on leverage, with a lower net debt burden relative to earnings.
IIIV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 63.0 | Neutral |
IIIV's weekly RSI is 51 (neutral) and its Stochastic is 63 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
IIIV PE vs Technology Sector
| Metric | IIIV | Sector median | Relative |
|---|---|---|---|
| PE | 44x | 28x | 59% above |
| PE % | 88 | 35 | 53 pts above |
IIIV is trading at 44x earnings, a 59% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over IIIV on valuation relative to its sector.
IIIV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.8 | 11% above |
| 20 week MA | $17.6 | 5.7% above |
| 50 week MA | $20.6 | 9.3% below |
| 100 week MA | $23.9 | 22% below |
| 200 week MA | $23.1 | 19% below |
IIIV has stronger trend alignment. IIIV is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
IIIV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.3 | $32.9 | +16% |
| 2021 | $32.9 | $23.2 | -29% |
| 2022 | $23.2 | $24.0 | +3.1% |
| 2023 | $24.0 | $21.2 | -12% |
| 2024 | $21.2 | $23.9 | +13% |
| 2025 | $23.9 | $26.2 | +9.4% |
| 2026 YTD | $26.2 | $18.6 | -29% |
IIIV has finished higher in four of the last six years. It's down 29% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over IIIV on returns for 2026, with the stronger performance.